Category: Medosis Newsroom
-
Zimmer Biomet Holdings, Inc. has announced that the U.S. Food and Drug Administration (FDA) granted ‘Breakthrough Device Designation’ for its new iodine…….
-
On October 21, 2025, Olympus Corporation announced the launch of THUNDERBEAT II, its next-generation hybrid surgical energy device designed for both……
-
On October 24, 2025, the U.S. Food & Drug Administration (FDA) approved Lynkuet, a once-daily, non-hormonal capsule for the treatment of moderate-to-severe…..
-
Earlier this month, Olympus Corporation, a global MedTech innovator, announced the launch of SecureFlex, a single-use fine-needle biopsy (FNB) device…….
-
The U.S. Food and Drug Administration (FDA) has approved Gazyva® (Obinutuzumab) for adult patients with active lupus nephritis (LN) who are receiving…..